China Universal Asset Management Company’s Sionna Therapeutics SION Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$316K Sell
7,186
-734
-9% -$29.4K 0.02% 311
2026
Q1
$318K Sell
7,920
-2,352
-23% -$89.8K 0.02% 307
2025
Q4
$423K Buy
10,272
+5,272
+105% +$200K 0.03% 275
2025
Q3
$147K Buy
+5,000
New +$109K 0.01% 354

Other funds holding SION

China Universal Asset Management Company's SION Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Sionna Therapeutics (SION) stake by 9.3% in Q2 2026, selling an estimated $29.4K and leaving 7,186 shares worth $316K. The position accounts for 0.02% of the portfolio, ranked #311.

China Universal Asset Management Company first reported a position in SION in Q3 2025 and has held it in 4 quarters since. The position peaked at $423K in Q4 2025. 17 funds tracked by Wall St. Rank hold SION as of Q2 2026.

  • China Universal Asset Management Company held 7,186 shares of Sionna Therapeutics worth $316K as of Q2 2026.
  • China Universal Asset Management Company sold 734 Sionna Therapeutics shares in Q2 2026, an estimated $29.4K.
  • Sionna Therapeutics made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #311 holding.
  • China Universal Asset Management Company first reported a position in Sionna Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • China Universal Asset Management Company's Sionna Therapeutics position peaked at $423K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.